Translational Neuropsychopharmacology
-
- $129.99
-
- $129.99
Publisher Description
This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.
More Books Like This
More Books by Trevor W. Robbins & Barbara J. Sahakian
Other Books in This Series
Neurotoxin Modeling of Brain Disorders — Life-long Outcomes in Behavioral Teratology
2016
Social Behavior from Rodents to Humans
2017
Inflammation-Associated Depression: Evidence, Mechanisms and Implications
2016
Neuropharmacology of New Psychoactive Substances (NPS)
2017
Behavioral Neuroscience of Orexin/Hypocretin
2017
Non-medical and illicit use of psychoactive drugs
2017